コンシューマーヘルス受託製造の市場規模、シェア、動向分析レポート：製品別、サービス別、最終用途別、地域別、セグメント予測、2025年～2030年

コンシューマーヘルス受託製造市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のコンシューマーヘルス食品の受託製造市場規模は2030年までに2,092億2,000万米ドルに達し、2025年から2030年までのCAGRは8.72％で成長すると予測されています。

現在、製薬・バイオ医薬品、栄養補助食品、化粧品、医療機器企業の大半は、収益性を高めるために効率性と費用対効果の高いソリューションを優先しています。したがって、製造のアウトソーシングは、コストの最適化、規制遵守、生産能力の向上のために不可欠となっています。さらにヘルスケア企業には、製造受託（CMO）施設を活用して生産を合理化したり、コアコンピタンスに集中する機会を得て市場成長を促進したりするなど、いくつかの利点があります。加えて、クリーンラベル製剤に対する要求の高まりや、機能性サプリメントに対する消費者の関心の高まりが、栄養補助食品やOTC医薬品の製造における技術革新を後押ししています。

さらに、セルフケアへの消費者の嗜好の変化は、コンシューマーヘルス製品の需要増加の重要な要因の一つであり、コンシューマーヘルス製品の受託製造の需要を促進しています。そのほか、OTC医薬品、栄養補助食品、化粧品、医療機器に対する需要の高まりによって、市場は急速に拡大しています。さらに、eコマースや流通プラットフォームの台頭により、拡張性と柔軟性のある製造ソリューションへのニーズが高まっています。さらに、FDA、EMA、GMPなどの機関による厳しい規制により、メーカーは高度な品質管理対策、連続化、コンプライアンス主導の生産を実施するようになっています。

さらに、AIを活用した自動化、リアルタイムの生産モニタリング、ブロックチェーンを活用したトレーサビリティなど、先進技術の導入が製造業のサプライチェーン効率を強化しています。受託製造機関（CMO）は、医薬品生産を進めるために、連続製造、自動化、AIを活用したプロセス最適化などの先進技術の採用を増やしています。こうした技術統合は、効率を高め、無駄を削減し、製品の品質と規制コンプライアンスを向上させる。

同様に、戦略的イニシアティブと製品上市の加速も市場を牽引します。例えば、2024年8月、アエノバはルーマニアの施設で新しいグミ生産ラインの開発を発表しました。食品サプリメントや医薬品の好ましい剤形としてグミの人気が高まっていることから、同社は2024年末までにこのラインを立ち上げる予定です。新ラインの年間生産能力はグミ約10億個と予測されています。このような取り組みにより、推定期間中、市場の牽引役となることが期待されます。

コンシューマーヘルス受託製造市場レポートハイライト

• 製品別では、一般用医薬品（OTC）分野が市場を独占し、2024年のシェアは33.25%でした。この成長の背景には、OTC医薬品の生産増加、セルフメディケーション動向の高まり、ヘルスケア意識の高まり、eコマースチャネルの拡大、OTC医薬品の市場投入の増加があります。
• サービス別では、原薬製造分野が2024年に最大の市場シェアを占めたが、これはOTC医薬品の需要要件が増加していることに起因しています。また、医薬品開発における技術革新により、効率性、拡張性、規制基準の遵守を目的とした製造受託機関（CMO）のニーズが高まっており、市場の拡大に拍車をかけています。
• 最終用途別では、製薬・バイオ医薬品企業が2024年に最大の市場シェアを占めました。これらの企業は、生産コストの削減、拡張性の向上、製品の市場投入期間の短縮のためにCMOサービスを利用しています。CMOは、包括的な製品開発のための専門的な製造ノウハウを提供します。製造サービスのアウトソーシングはさらに、革新的な技術、適応可能な生産能力、最適化された世界・サプライチェーン管理へのアクセスを提供します。
• アジア太平洋地域は、日本、中国、インドなどの国々でヘルスケア企業や製造受託機関（CMO）の数が増加しているため、予測期間中にCAGR 9.48%と最も速い成長率を記録すると予想されます。さらに、米国よりも比較的低コストで熟練した労働力を確保できることも、この地域での市場拡大に大きく貢献すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 コンシューマーヘルス受託製造市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 技術の進歩
• 価格モデル分析
• 市場分析ツール
  • ポーターのファイブフォース分析
  • SWOT分析によるPESTEL
  • COVID-19の影響分析

第4章 コンシューマーヘルス受託製造市場：製品の推定・動向分析

• コンシューマーヘルス受託製造市場：セグメントダッシュボード
• コンシューマーヘルス受託製造市場：変動分析
• 製品別、2018年～2030年
• 市販薬（OTC薬）
• 栄養補助食品
• パーソナルケア製品
• 医療機器
• その他

第5章 コンシューマーヘルス受託製造市場：サービスの推定・動向分析

• コンシューマーヘルス受託製造市場：セグメントダッシュボード
• コンシューマーヘルス受託製造市場：変動分析
• サービス別、2018年～2030年
• API製造
• 完成品製造
• 医療機器製造
• 包装とラベル
• その他

第6章 コンシューマーヘルス受託製造市場：最終用途の推定・動向分析

• コンシューマーヘルス受託製造市場：セグメントダッシュボード
• コンシューマーヘルス受託製造市場：変動分析
• 最終用途別、2018年～2030年
• 製薬・バイオ医薬品企業
• 栄養補助食品会社
• 化粧品会社
• 医療機器企業
• その他

第7章 コンシューマーヘルス受託製造市場：地域の推定・動向分析

• 地域別市場シェア分析、2024年および2030年
• 地域市場ダッシュボード
• 世界地域市場のスナップショット
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • タイ
  • 韓国
  • オーストラリア
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 市場参入企業の分類
• 企業市場シェア分析、2023/24年
• 企業プロファイル
  • Lonza
  • Recipharm AB
  • Piramal Consumer Products
  • Scapa Healthcare
  • Catalent, Inc
  • SCN BestCo
  • Aenova Group
  • Ventiz Healthcare
  • Bionova
  • Aurohealth
  • Siegrified AG
  • Thermo Fisher Scientific Inc
  • Famar
  • Sirio Pharma Co., Ltd
  • Tishcon Corporation
  • Vit-Best Nutrition Inc

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 4 Global Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 5 Global Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 6 North America Consumer Health Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
• Table 7 North America Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 8 North America Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 9 North America Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 10 U.S. Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 11 U.S. Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 12 U.S. Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 13 Canada Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 14 Canada Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 15 Canada Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 16 Mexico Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 17 Mexico Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 18 Mexico Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 19 Europe Consumer Health Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
• Table 20 Europe Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 21 Europe Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 22 Europe Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 23 UK Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 24 UK Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 25 UK Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 26 France Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 27 Germany Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 28 Germany Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 29 Germany Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 30 France Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 31 France Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 32 Italy Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 33 Italy Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 34 Italy Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 35 Spain Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 36 Spain Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 37 Spain Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 38 Denmark Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 39 Denmark Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 40 Denmark Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 41 Sweden Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 42 Sweden Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 43 Sweden Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 44 Norway Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 45 Norway Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 46 Norway Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific Consumer Health Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 51 Japan Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 52 Japan Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 53 Japan Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 54 China Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 55 China Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 56 China Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 57 India Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 58 India Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 59 India Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 60 Thailand Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 61 Thailand Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 62 Thailand Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 63 South Korea Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 64 South Korea Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 65 South Korea Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 66 Australia Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 67 Australia Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 68 Australia Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 69 Latin America Consumer Health Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
• Table 70 Latin America Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 71 Latin America Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 72 Latin America Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 73 Brazil Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 74 Brazil Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 75 Brazil Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 76 Argentina Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 77 Argentina Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 78 Argentina Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 79 Middle East & Africa Consumer Health Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 83 South Africa Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 84 South Africa Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 85 South Africa Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 89 UAE Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 90 UAE Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 91 UAE Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 92 Kuwait Consumer Health Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
• Table 93 Kuwait Consumer Health Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
• Table 94 Kuwait Consumer Health Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
• Table 95 Financial performance

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Market formulation & validation
• Fig. 6 Commodity flow analysis
• Fig. 7 Value-chain-based sizing & forecasting
• Fig. 8 QFD model sizing & forecasting
• Fig. 9 Bottom-up approach
• Fig. 10 Market snapshot
• Fig. 11 Segment snapshot 1
• Fig. 12 Segment snapshot 2
• Fig. 13 Competitive landscape snapshot
• Fig. 14 Parent market outlook, 2024 (USD Billion)
• Fig. 15 Ancillary market outlook, 2024 (USD Billion)
• Fig. 16 Consumer Health Contract Manufacturing Market dynamics
• Fig. 17 Porter's five forces analysis
• Fig. 18 PESTEL analysis
• Fig. 19 Consumer Health Contract Manufacturing Market: Product outlook and key takeaways
• Fig. 20 Consumer Health Contract Manufacturing Market: Product movement analysis
• Fig. 21 Over-the-counter (OTC) Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Nutritional Supplements Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Personal Care Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Medical Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Consumer Health Contract Manufacturing Market: Manufacturing outlook and key takeaways
• Fig. 27 Consumer Health Contract Manufacturing Market: Manufacturing movement analysis
• Fig. 28 API Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Finished Dose Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Medical Device Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Packaging & Labelling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Consumer Health Contract Manufacturing Market: End Use outlook and key takeaways
• Fig. 34 Consumer Health Contract Manufacturing Market: End Use movement analysis
• Fig. 35 Pharmaceutical & Biopharmaceutical Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Pharmaceutical & Biopharmaceutical Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Nutraceutical Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Cosmeceutical Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Medical Device Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Regional Marketplace: Key Takeaways
• Fig. 42 North America Consumer Health Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
• Fig. 43 Key country dynamics
• Fig. 44 U.S. Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Key country dynamics
• Fig. 46 Canada Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Key country dynamics
• Fig. 48 Mexico Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Europe Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Key country dynamics
• Fig. 51 UK Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Key country dynamics
• Fig. 53 Germany Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Key country dynamics
• Fig. 55 France Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Key country dynamics
• Fig. 57 Italy Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Key country dynamics
• Fig. 59 Spain Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Key country dynamics
• Fig. 61 Denmark outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Key country dynamics
• Fig. 63 Sweden outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Key country dynamics
• Fig. 65 Norway outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Asia Pacific Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Key country dynamics
• Fig. 68 Japan Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Key country dynamics
• Fig. 70 China Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Key country dynamics
• Fig. 72 India Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Key country dynamics
• Fig. 74 Thailand Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Key country dynamics
• Fig. 76 South Korea Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Key country dynamics
• Fig. 78 Australia Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Latin America Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 80 Key country dynamics
• Fig. 81 Brazil Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Key country dynamics
• Fig. 83 Argentina Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 84 MEA Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 85 Key country dynamics
• Fig. 86 South Africa Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 87 Fig. Key country dynamics
• Fig. 88 Saudi Arabia Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 89 Key country dynamics
• Fig. 90 UAE Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 91 Key country dynamics
• Fig. 92 Kuwait Consumer Health Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 93 Key company categorization
• Fig. 94 Service heat map analysis
• Fig. 95 Strategic framework

Consumer Health Contract Manufacturing Market Growth & Trends:

The global consumer health contract manufacturing market size is expected to reach USD 209.22 billion by 2030, growing at a CAGR of 8.72% from 2025 to 2030, according to a new report by Grand View Research, Inc. Currently, most of the pharmaceutical & biopharmaceutical, nutraceutical, cosmeceutical, and medical device companies prioritize efficiency and cost-effective solution to enhance profitability; hence, outsourcing manufacturing has become essential for cost optimization, regulatory compliance, and improved production capabilities. Moreover, several benefits are offered to healthcare companies, such as the ability to utilize contract manufacturing (CMO) facilities to streamline production and the opportunity to focus on core competencies and drive market growth. Besides, the rising requirement for clean-label formulations and consumers' increasing interest in functional supplements drive innovation in nutraceutical and OTC drug manufacturing.

In addition, shifting consumer preferences toward self-care is one of the significant factors for the rising demand for consumer health products that have fueled the demand for consumer health contract manufacturing. Besides, the market is experiencing rapid expansion driven by rising demand for OTC drugs, dietary supplements, cosmeceuticals, and medical devices. In addition, the rising e-commerce and distribution platforms have led to an increasing need for scalable and flexible manufacturing solutions. Furthermore, stringent regulations from bodies like the FDA, EMA, and GMP have led manufacturers to implement advanced quality control measures, serialization, and compliance-driven production.

Furthermore, the incorporation of advanced technologies, including AI-driven automation, real-time production monitoring, and blockchain-based traceability, is strengthening supply chain efficiency in manufacturing. Contract manufacturing organizations (CMOs) increasingly adopt advanced technologies such as continuous manufacturing, automation, and AI-powered process optimization to advance pharmaceutical production. These technological integrations enhance efficiency, reduce waste, and improve product quality and regulatory compliance.

Likewise, strategic initiatives and accelerating product launches drive the market. For instance, in August 2024, Aenova announced the development of a new gummy production line at its Romania facility. With the rising popularity of gummies as a preferred dosage form for food supplements and pharmaceuticals, the company plans to launch the line by the end of 2024. The new line is projected to have an annual production capacity of approximately one billion gummies. Such initiatives are expected to drive the market over the estimated time period.

Consumer Health Contract Manufacturing Market Report Highlights:

• Based on product, the over-the-counter (OTC) drugs segment dominated the market, with a share of 33.25% in 2024. This growth is driven by increased OTC drug production, rising self-medication trends, growing healthcare awareness, expanding e-commerce channels, and growing launches of OTC drugs in the market
• Based on service, the API manufacturing segment held the largest market share in 2024, attributed to the increasing requirements demand for OTC drugs. Besides, innovations in drug development have increased the need for contract manufacturing organizations (CMOs) for their efficiency, scalability, and adherence to regulatory standards, further fueling market expansion
• Based on end-use, the pharmaceutical & biopharmaceutical companies segment held the largest market share in 2024. These companies utilize CMO services to reduce production costs, enhance scalability, and accelerate product time-to-market. CMOs offer specialized manufacturing expertise for comprehensive product development. Outsourcing manufacturing services further provides access to innovative technologies, adaptable production capabilities, and optimized global supply chain management
• Asia Pacific is expected to register the fastest growth rate of 9.48% CAGR over the forecast period due to the rising number of healthcare companies and contract manufacturing organizations(CMOs) in countries such as Japan, China, and India. In addition, the availability of a skilled workforce at comparatively lower costs than in the U.S. is expected to significantly contribute to the market's expansion in this region

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Parent Market Analysis
• 1.8. List Of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Consumer Health Contract Manufacturing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Technological Advancements
• 3.4. Pricing Model Analysis
• 3.5. Market Analysis Tools
  • 3.5.1. Porter's Five Analysis
  • 3.5.2. PESTEL by SWOT Analysis
  • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Consumer Health Contract Manufacturing Market: Product Estimates & Trend Analysis

• 4.1. Consumer Health Contract Manufacturing Market, By Product: Segment Dashboard
• 4.2. Consumer Health Contract Manufacturing Market, By Product: Movement Analysis
• 4.3. Consumer Health Contract Manufacturing Market Estimates & Forecasts, By Product, 2018 - 2030
• 4.4. Over-the-counter (OTC) Drugs
  • 4.4.1. Over-the-counter (OTC) Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Nutritional Supplements
  • 4.5.1. Nutritional Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Personal Care Products
  • 4.6.1. Personal Care Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Medical Devices
  • 4.7.1. Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Consumer Health Contract Manufacturing Market: Service Estimates & Trend Analysis

• 5.1. Consumer Health Contract Manufacturing Market, By Service: Segment Dashboard
• 5.2. Consumer Health Contract Manufacturing Market, By Service: Movement Analysis
• 5.3. Consumer Health Contract Manufacturing Market Estimates & Forecasts, By Service, 2018 - 2030
• 5.4. API Manufacturing
  • 5.4.1. API Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Finished Dose Manufacturing
  • 5.5.1. Finished Dose Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Medical Device Manufacturing
  • 5.6.1. Medical Device Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Packaging & Labelling
  • 5.7.1. Packaging & Labelling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Consumer Health Contract Manufacturing Market: End Use Estimates & Trend Analysis

• 6.1. Consumer Health Contract Manufacturing Market, By End Use: Segment Dashboard
• 6.2. Consumer Health Contract Manufacturing Market, By End Use: Movement Analysis
• 6.3. Consumer Health Contract Manufacturing Market Estimates & Forecasts, By End Use, 2018 - 2030
• 6.4. Pharmaceutical & Biopharmaceutical Companies
  • 6.4.1. Pharmaceutical & Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Nutraceutical Companies
  • 6.5.1. Nutraceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Cosmeceutical Companies
  • 6.6.1. Cosmeceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Medical Device Companies
  • 6.7.1. Medical Device Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Others
  • 6.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Consumer Health Contract Manufacturing Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. North America
  • 7.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. U.S
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Denmark
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Norway
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Thailand
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. South Korea
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Australia
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Company Market Share Analysis, 2023/24
• 8.3. Company Profiles
  • 8.3.1. Lonza
    • 8.3.1.1. Company Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Service Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. Recipharm AB
    • 8.3.2.1. Company Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Service Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. Piramal Consumer Products
    • 8.3.3.1. Company Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Service Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. Scapa Healthcare
    • 8.3.4.1. Company Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Service Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. Catalent, Inc
    • 8.3.5.1. Company Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Service Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. SCN BestCo
    • 8.3.6.1. Company Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Service Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. Aenova Group
    • 8.3.7.1. Company Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Service Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. Ventiz Healthcare
    • 8.3.8.1. Company Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Service Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Bionova
    • 8.3.9.1. Company Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Service Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. Aurohealth
    • 8.3.10.1. Company Overview
    • 8.3.10.2. Financial Performance
    • 8.3.10.3. Service Benchmarking
    • 8.3.10.4. Strategic Initiatives
  • 8.3.11. Siegrified AG
    • 8.3.11.1. Company Overview
    • 8.3.11.2. Financial Performance
    • 8.3.11.3. Service Benchmarking
    • 8.3.11.4. Strategic Initiatives
  • 8.3.12. Thermo Fisher Scientific Inc
    • 8.3.12.1. Company Overview
    • 8.3.12.2. Financial Performance
    • 8.3.12.3. Service Benchmarking
    • 8.3.12.4. Strategic Initiatives
  • 8.3.13. Famar
    • 8.3.13.1. Company Overview
    • 8.3.13.2. Financial Performance
    • 8.3.13.3. Service Benchmarking
    • 8.3.13.4. Strategic Initiatives
  • 8.3.14. Sirio Pharma Co., Ltd
    • 8.3.14.1. Company Overview
    • 8.3.14.2. Financial Performance
    • 8.3.14.3. Service Benchmarking
    • 8.3.14.4. Strategic Initiatives
  • 8.3.15. Tishcon Corporation
    • 8.3.15.1. Company Overview
    • 8.3.15.2. Financial Performance
    • 8.3.15.3. Service Benchmarking
    • 8.3.15.4. Strategic Initiatives
  • 8.3.16. Vit-Best Nutrition Inc
    • 8.3.16.1. Company Overview
    • 8.3.16.2. Financial Performance
    • 8.3.16.3. Service Benchmarking
    • 8.3.16.4. Strategic Initiatives